Copyright: ©Author(s) 2026.
World J Methodol. Sep 20, 2026; 16(3): 117065
Published online Sep 20, 2026. doi: 10.5662/wjm.117065
Published online Sep 20, 2026. doi: 10.5662/wjm.117065
Table 2 Oral anticoagulant adherence
| Ref. | Intervention/trial name | Adherence metric | Follow-up | Key finding | Interpretation |
| Studies reporting a positive effect on adherence | |||||
| Yoon et al[32], 2024 | ADHERE-app (Alerts + monitoring) | Pill count (≥ 95% threshold) | 6 months | Proportion with adequate adherence (≥ 95%) significantly higher in intervention (73.9% vs 61.0%; P = 0.007) | Intervention increased the likelihood of achieving high adherence |
| Hsieh et al[35], 2021 | Web-based integrated program | MARS (self-report scale) | 6 months | Significantly greater improvement in adherence vs control over time (GEE analysis, P = 0.001) | Sustained improvement in self-reported adherence |
| Xu et al[36], 2024 | Alfalfa app (education + consultation) | MMAS-8 (self-report scale) | 3 months | Medication compliance significantly higher at 1 and 3 months (all P < 0.05) | Short-term improvement in self-reported adherence |
| Guo et al[31], 2017 | mAFA pilot (mAF app) | 3-item adherence estimator | 3 months | Drug adherence significantly better at 1 and 3 months (all P < 0.05) | Early improvement in adherence with integrated app |
| Magnani et al[37], 2025 | Rural AF intervention (agent + monitor) | 3-item self-report instrument | 4 and 8 months | Self-reported adherence significantly higher (OR = 1.89) | Positive subjective effect, despite no objective difference |
| Guo et al[30], 2020 | mAFA-II (dynamic management) | OAC usage/uptake | 12 months | OAC use increased in intervention (63.4% to 70.2%) but decreased in control (P < 0.001) | Intervention improved OAC persistence at a population level |
| Studies reporting no significant difference in objective adherence | |||||
| Yoon et al[32], 2024 | ADHERE-app (alerts + monitoring) | Pill count (continuous median) | 6 months | No difference in median adherence (98% vs 97.5%; P = 0.15). | High baseline adherence in both groups limited improvement |
| Turakhia et al[33], 2021 | SmartADHERE (blended support) | PDC | 6 months | No difference in mean PDC (0.86 vs 0.88; P = 0.62) or PDC ≥ 80% | Exceptionally high adherence in control group (“ceiling effect”) |
| Tran et al[38], 2022 | BOAT-OAR (ECG + organizer) | Pill Count (median) | 5.9 months | No difference in median compliance (100% vs 99.7%; P = 0.247) | Near-perfect adherence in both groups |
| Magnani et al[37], 2025 | Rural AF intervention (agent + monitor) | PDC | 12 months | No difference in 12-month PDC (median 0.97 both groups) | Objective measure did not confirm self-reported benefits |
- Citation: Farhan M, Patel T, Harazeen W, Mohamed Y, Al Azzawi A, Intabli H, Ahmed N, Obais MAHN, Alkhazali MR, Patel BD, Ahmad A, Awosika A. Smartphone-based mobile health impact on oral anticoagulation adherence, quality of life, and healthcare utilization in adult atrial fibrillation. World J Methodol 2026; 16(3): 117065
- URL: https://www.wjgnet.com/2222-0682/full/v16/i3/117065.htm
- DOI: https://dx.doi.org/10.5662/wjm.117065